| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0098 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |